CYNTHIA BRINDLE: Open Payments
NPI 1841880507 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 82 payments from 17 companies in 2025. Trend: 2023 $412 · 2024 $622 · 2025 $1,277
Food & beverage: $1,217Education: $59
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $268 |
| Vanda Pharmaceuticals Inc. | 14 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $121 |
| Teva Pharmaceuticals USA, Inc. | 4 | $82 |
| Neurocrine BioSciences, Inc. | 4 | $80 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Lundbeck LLC | 3 | $54 |
Products named: VRAYLAR, FANAPT, CAPLYTA, INGREZZA, COBENFY, AUSTEDO XR, Jornay PM, Auvelity.
Industry payments across IN — which companies pay providers there.
